Community-based Brain Health Program to Address Dementia Risk
| 대상 질환 | Dementia, Alzheimer Disease |
|---|---|
| 임상 단계 | 단계 해당 없음 |
| 스폰서 | Posit Science Corporation |
| 상태 | 완료 |
| 참여자 수 | 86 명 |
| 중재(약물) | Brain Health Program |
| 시작일 | 2023년 4월 24일 |
| 완료일 | 2024년 10월 18일 |
| 결과 공개일 | 2026년 7월 27일 |
요약
This is a validation study to evaluate the acceptability, feasibility and preliminary efficacy of the Brain Health Program, a multimodal curriculum covering dementia risk factors and evidence-based change interventions. The goal of this study is to evaluate the Brain Health Program in individuals with identified risk factors for the onset of dementia and to prepare for a large-scale efficacy trial in this population.
Net Promoter Score
| Brain Health Program | 65 score on a scale |
|---|
BENITIONS에서 보기 ClinicalTrials.gov 원문 보기
같은 질환의 다른 임상
- Brain Energy for Amyloid Transformation in Alzheimer's Disease Study — Wake Forest University Health Sciences
- Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss — Eli Lilly and Company
- Using a Wireless Controller to Deliver a Lighting Intervention to Persons With Dementia — Icahn School of Medicine at Mount Sinai
- Deprescribing in Patients Living With Dementia With Caregiver and Provider Nudges — Brigham and Women's Hospital
- Technology and Family Thriving Study — University of California, Santa Barbara
- Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzhei — Georgetown University